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Arc/Arg3.1 is an effector immediate-early gene impli-
cated in the consolidation of memories. Although
cloned a decade ago, the physiological role of Arc/
Arg3.1 in the brain has remained elusive. Four papers
in this issue of Neuron address this function. These
studies show that Arc/Arg3.1 regulates endophilin 3
and dynamin 2, two components of the endocytosis
machinery. Genetic ablation of Arc/Arg3.1 in mice or
overexpression in culture suggest that Arc/Arg3.1 reg-
ulates AMPA receptor trafficking and synaptic plastic-
ity. Finally, Arc/Arg3.1 knockout mice show memory
retention deficits. These recent developments provide
new insights into the function of this popular activity-
dependent neuronal marker.
The molecular mechanisms for the induction and stabili-
zation of synapse strengthening during learning and
memory has become a major focus of cellular neurosci-
ence over the past two decades (Bredt and Nicoll, 2003).
The recognition that high-frequency stimulation of af-
ferent fibers in hippocampus can lead to long-term
changes in synaptic strength (i.e., LTP) provided a means
to study synaptic plasticity at the cellular level. Early
studies using pharmacological manipulations of recep-
tor and kinase function concluded that LTP, a presumed
synaptic correlate of memory (Whitlock et al., 2006), re-
quires calcium influx through NMDA receptors leading
to rapid insertion of AMPA receptors (Malenka and Nic-
oll, 1999). However, for LTP or any other form of synaptic
plasticity to underlie learning and memory, a persistent
modification of synapses is necessary. Most likely, any
long-lasting change would depend on rapid induction
of gene transcription and subsequent protein synthesis.
Therefore, in parallel to studies that focused on the
immediate molecular mechanism of the strengthening
stimulus, several groups pursued research involving
transcription-dependent changes. Initial evidence into
the relationship between intense synaptic activity and
rapid transient gene expression came from studies in-
volving the immediate-early gene (IEG) c-fos (Morgan
et al., 1987). The demonstration that calcium influx, in re-
sponse to cholinergic receptor activation, could induce
c-fos transcription suggested a mechanism to link elec-
trical activity to gene regulation (Greenberg et al., 1986).
Soon afterwards several papers were published identify-
ing many more activity-induced IEGs and, in particular,
linking this induction to LTP-inducing stimuli (Cole
et al., 1989). An IEG is defined as a gene that is rapidly
and transiently activated at the transcriptional level
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cmp.ucsf.edu (R.A.N.)following robust synaptic, neurotransmitter, or growth
factor stimulation (for extensive review of the early IEG
literature see Sheng and Greenberg, 1990).
The first collection of IEGs encoded transcription fac-
tors. This indicated that IEGs might not have a direct role
in synapse strengthening but rather would orchestrate
the expression of genes encoding proteins that might
be more intimately involved in synaptic plasticity and
memory formation. This realization led to a search for
IEGs that might play such a role. Using subtractive clon-
ing techniques to identify mRNAs from hippocampus in-
duced by the maximal electroconvulsive seizure method
(MECS), Paul Worley and colleagues isolated several
IEGs that are now collectively known as effector IEGs
(see Guzowski, 2002 for an extensive review). Effector
IEGs encode for growth factors (BDNF, b-activin), signal
transduction molecules (Homer 1a, Rheb), metabolic
enzymes (COX-2), and cell surface proteins (Arcadlin,
Narp). Another such effector IEG that the Worley group
identified is Arc (Lyford et al., 1995). Concomitantly
and independently of Worley’s group, Dietmar Kuhl
also isolated Arc from hippocampus, under the name
Arg3.1, using similar cloning methods (Link et al., 1995).
Arc/Arg3.1 is expressed in the brain and is rapidly ac-
tivated by robust patterned synaptic activity, including
natural stimuli, seizures, LTP, and memory-related be-
havioral paradigms (for review see Guzowski, 2002).
Localization studies have determined that, following
a behavioral experience, Arc/Arg3.1 is selectively ex-
pressed in CaMKII-positive glutamatergic neurons in
the forebrain (Vazdarjanova et al., 2006) and that Arc/
Arg3.1 binds to and is phosphorylated by CaMKII (Donai
et al., 2003). Arc/Arg3.1 protein is found in the postsyn-
aptic density (PSD), copurifies with the NMDA recep-
tor complex (Husi et al., 2000; Steward and Worley,
2001a), and, like many IEGs, its induction in vivo requires
NMDA receptor activation (Link et al., 1995; Steward and
Worley, 2001b). In a series of elegant experiments, Stew-
ard and Worley (2001a, 2001b) found that newly synthe-
sized Arc/Arg3.1 mRNA is rapidly delivered to dendrites
and accumulates selectively in the band of synapses that
had been activated. Remarkably, when this experiment
was repeated following electroconvulsive seizures,
which caused a uniform dendritic expression of Arc/
Arg3.1 mRNA, local stimulation caused a band to appear
in which preexisting dendritic mRNA was redistributed
within minutes from inactive synapses to the activated
synapses in an NMDA receptor-dependent manner (Fig-
ure 1). However, NMDA receptor activation is not the sole
mechanism to induceArc/Arg3.1mRNA transcription. In
PC12 cells and dissociated hippocampal neurons, mem-
brane depolarization and subsequent calcium influx
through voltage-gated calcium channels also induces
Arc/Arg3.1 mRNA synthesis. In these reduced systems,
cAMP can also trigger synthesis of Arc/Arg3.1 mRNA.
Calcium and cAMP both induceArc/Arg3.1 transcription
through PKA. MAPK is also implicated in the cAMP-de-
pendent activation of Arc/Arg3.1 (Waltereit et al., 2001).
A more recent study, also using cultured dissociated hip-
pocampal neurons as well as slice cultures, suggested
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NMDA and AMPA receptors. NMDA receptor activation
increases Arc/Arg3.1 levels while AMPA receptor acti-
vation decreases them, surprisingly, via a pertussis
toxin-sensitive G protein (Rao et al., 2006).
Arc/Arg3.1 as an Activity Neuronal Marker
A critical goal of neuroscience is to relate the activity of
neural circuits to behavior. The unraveling of this rela-
tionship was for several decades the purview of electro-
physiology, but this has recently changed due to the
rapid emergence of technologies integrating molecular
biology and imaging techniques. Because elevated ex-
pression of Arc/Arg3.1 mRNA in the dendrites of neu-
rons is readily observed following neural activation,
Arc/Arg3.1 expression has been used as a marker of
neuronal activity throughout the brain.
In 1999, Guzowski et al. published a seminal paper de-
scribing a new approach to the study of neural networks
using Arc/Arg3.1 as a marker (Guzowski et al., 1999).
The technique is referred to as cellular compartment
analysis of temporal activity by fluorescent in-situ hy-
bridization, or catFISH. Although catFISH does not pro-
vide real-time information on the activity of neural en-
sembles, it provides knowledge on the activity history
of neurons with both temporal and cellular resolution.
At the heart of this technique are the different time
courses of nuclear Arc/Arg3.1 pre-mRNA and cytoplas-
mic Arc/Arg3.1 mRNA (Wallace et al., 1998). Within 2 min
after the induction of a behavioral experience or other
Arc/Arg3.1-inducing stimuli, Arc/Arg3.1 pre-mRNA ap-
pears in neuronal nuclei, and by around 20 min it has dis-
appeared from the nucleus as the processed mRNA
moves to the cytoplasm (Wallace et al., 1998). Detection
of cytoplasmic Arc/Arg3.1 mRNA using catFISH occurs
w20–45 min postinduction. Therefore, after two behav-
ioral experiences separated by at least 20 min, neurons
that are active during both experiences have both nu-
clear and cytoplasmic Arc/Arg3.1 mRNA, while neurons
Figure 1. Selective Targeting of Arc/Arg3.1 mRNA to Active Den-
dritic Domains after Induction of Electroconvulsant Seizure
(Left) High-power view of the distribution of Arc/Arg3.1 mRNA in the
dentate gyrus contralateral to the stimulation where Arc/Arg3.1 ex-
pression had been induced by the ECS. (Right) High-power view of
the distribution of Arc/Arg3.1 mRNA in the dentate gyrus that had
received perforant path stimulation. From Steward and Worley
(2001b).active in only one of the two experiences would have ei-
ther nuclear or cytoplasmic Arc/Arg3.1 mRNA expres-
sion (see Guzowski et al., 2001, for a detailed review
of catFISH and its more recent variant, double-label
catFISH).
Thus, Arc/Arg3.1 catFISH can determine the activity
history of an individual neuron, the spatial distribution
of thousands of activated neurons, and the visualization
of neural ensembles activated by two distinct behavioral
experiences. In addition, catFISH bypasses the inability
to monitor the neural activity from many distinct ana-
tomical regions, a shortcoming of electrophysiological
techniques. Many recent studies using either conven-
tional Arc/Arg3.1 in situ hybridization or Arc/Arg3.1
catFISH display the utility of Arc/Arg3.1 as an activity
neuronal marker. For example, Bruce McNaughton,
Carol Barnes, and colleagues have shown that sequen-
tial exposure of rats to two distinct environments leads
to activation of different neuronal ensembles in the hip-
pocampus (Guzowski et al., 1999). Using catFISH, this
group also probed the relationship between the hippo-
campus and the parietal and gustatory cortices during
different behavioral experiences (Burke et al., 2005).
Furthermore, with Arc/Arg3.1 as a reporter, Tagawa
et al. suggested that neuronal plasticity in the mouse
visual cortex differs from that in cats and monkeys
(Tagawa et al., 2005), while Zou and Buck used Arc/
Arg3.1 to study the coding of odor mixtures in the cortex
(Zou and Buck, 2006). Lastly, Temple et al. used experi-
ence-induced Arc/Arg3.1 to visualize neural circuit
remodeling after brain injury (Temple et al., 2003).
Arc/Arg3.1 and AMPA Receptor Trafficking
The general picture that emerged from these studies
was that Arc/Arg3.1 localizes to synapses in an activ-
ity-dependent manner. For many years after its discov-
ery, Arc/Arg3.1 was searching for a function beyond
that of an activity-dependent neuronal marker. A series
of recently published papers, including the ones pub-
lished in this issue of Neuron, demonstrate that Arc/
Arg3.1 functions to regulate AMPA receptor trafficking.
The study of Chowdhury et al. (2006) establishes a
direct link between endocytosis and Arc/Arg3.1. Using
several biochemical assays, they showed that Arc/
Arg3.1 directly interacts with endophilin 3 and dynamin
2, two proteins involved in the endocytosis of membrane
vesicles. Arc/Arg3.1 binds to dynamin 2 and endophilin
3 through distinct nonoverlapping domains. Dynamin
2 is a member of the dynamin GTPase superfamily
(Praefcke and McMahon, 2004) and is involved in the
scission of invaginated clathrin-coated vesicles from
the plasma membrane. Dynamins bind directly to phos-
pholipids through a pleckstrin homology domain (PH)
and are involved in protein-protein interactions through
a proline-rich domain (PRD) (Hinshaw, 2000). Perhaps
unexpectedly, binding of Arc/Arg3.1 to dynamin 2 is
through the PH domain and not through the PRD. Endo-
philin 3 is a cytoplasmic Src-homology 3 (SH3)-contain-
ing protein found at the PSD. Endophilins interact with
dynamin and amphiphysin to mediate/regulate cla-
thrin-mediated vesicle recycling (Conner and Schmid,
2003). Endophilins also contain an N-terminal Bin/am-
phiphysin/Rvs (N-BAR) domain that is implicated in the
recognition of curved membranes. BAR domains are
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charged membranes (McMahon and Gallop, 2005). Like
the Arc/Arg3.1-dynamin 2 interaction, Arc/Arg3.1 binds
to endophilin not via the typical protein-protein interac-
tion SH3 domain but instead through the BAR domain.
As the regulation of AMPA receptor exocytosis and
endocytosis underlies synaptic plasticity in many brain
regions (Bredt and Nicoll, 2003), Chowdhury et al. tested
whether Arc/Arg3.1 could regulate AMPA receptor sur-
face expression (Chowdhury et al., 2006). Using disso-
ciated hippocampal neurons, the authors show that
overexpression (w16 hr) of Arc/Arg3.1 downregulates
surface expression of AMPA receptors (w50%) through
an increased rate of AMPA receptor endocytosis. The in-
teraction of Arc/Arg3.1 with dynamin 2 and endophilin 3
is critical for the trafficking phenotype since mutant Arc/
Arg3.1 that cannot bind to either dynamin 2 or endophi-
lin 3 has no effect on AMPA receptor surface expression.
However, Arc/Arg3.1 overexpression is also accompa-
nied by a significant loss of total AMPA receptor protein
(w30%) through an unknown mechanism. In support of
the conclusion that Arc/Arg3.1 regulates AMPA receptor
surface expression, cultured hippocampal neurons
prepared from Arc/Arg3.1 knockout mice showed a
2-fold increase in AMPA receptor surface expression,
increased miniature EPSCs amplitudes (mEPSCs), and
a decreased rate of endocytosis (Shepherd et al.,
2006). Furthermore, in an accompanying paper by Rial
Verde et al. (2006), overexpression of Arc/Arg3.1 in orga-
notypic hippocampal slice cultures induced a reduction
of both AMPA receptor surface expression and AMPA
receptor-mediated synaptic transmission (w30% loss),
assayed either through evoked synaptic stimulation
or through recordings of mEPSCs. The Arc/Arg3.1
phenotype was selective, as no change was found in
either NMDA receptor- or GABA-mediated synaptic
transmission.
Although these studies have provided persuasive ev-
idence that Arc/Arg3.1 regulates basal AMPA receptor
surface expression and synaptic transmission, record-
ings from acute hippocampal slices prepared from
Arc/Arg3.1 knockout mice do not fully corroborate these
conclusions. Arc/Arg3.1 knockout mice and wild-type
mice have similar input-output curves, a measure of
basal synaptic transmission, and identical mEPSC am-
plitudes and frequency (Plath et al., 2006). Perhaps the
reason for this discrepancy lies in the different experi-
mental approaches. For example, in vivo Arc/Arg3.1 is
expressed predominantly following a bout of robust
synaptic activity such as that given to induce LTP. How-
ever, high-frequency stimulation not only activates Arc/
Arg3.1 but also several other signaling cascades that
would regulate AMPA receptor trafficking in parallel.
In the in vitro culture assays, Arc/Arg3.1 overexpres-
sion might overshadow the contribution of other AMPA
receptor trafficking regulatory mechanisms, possibly
leading to a more extreme phenotype. In further support
of this notion, Adesnik et al. (2005) demonstrated that
the basal recycling of native AMPA receptors is slow
(w16 hr) compared to the turnover rate estimated using
overexpressed AMPA receptors (Passafaro et al., 2001).
Furthermore, the limiting factor for AMPA anchoring in
synapses is the presence of MAGUK molecules such
as PSD-95 (Elias et al., 2006; Schnell et al., 2002). Previ-ously, Worley and colleagues had suggested that Arc/
Arg3.1 (S. Chowdhury et al., 2002, Soc. Neurosci., ab-
stract #746.13) might associate with PSD-95 through
its SH3-GK domain. If this is indeed the case, Arc/
Arg3.1 overexpression might bind to and deplete PSD-
95 molecules in the synapse, causing a reduction in
the synaptic AMPA receptors levels. This would be inde-
pendent of the Arc/Arg3.1-induced changes in endocy-
tosis. Further studies are needed to distinguish between
the different possibilities.
Arc/Arg3.1 in Synaptic Plasticity and Behavior
Currently, there are several forms of synaptic plasticity,
all of which may contribute to memory formation: LTP,
LTD, and more recently homeostatic synaptic plasticity.
These various forms of plasticity typically involve inser-
tion or removal of AMPA receptors from the synapse
(Bredt and Nicoll, 2003). It has long been suggested
that Arc/Arg3.1 might contribute directly to the longer
phases of LTP and consequently memory formation be-
cause paradigms that induce robust synapse strength-
ening lead to the rapid induction of Arc/Arg3.1.
In 2000, Guzowski et al. provided the first experimen-
tal evidence that Arc/Arg3.1 regulates the late phases of
LTP (Guzowski et al., 2000). The authors delivered Arc/
Arg3.1 antisense oligonucleotides (AOD) into the hip-
pocampus of awake behaving rats in a manner that
blocked the transient increase of Arc/Arg3.1 mRNA/pro-
tein following high-frequency stimulation. This manipu-
lation had little effect on LTP during the first 4 hr, but
LTP decayed subsequently and by the fifth day had re-
turned to baseline. Consistent with the electrophysio-
logical findings, rats treated with Arc/Arg3.1 AODs
soon after a spatial water task showed impaired memory
consolidation, while rats treated 8 hr after the learning
task, a time when poststimulation Arc/Arg3.1 levels are
in decline, showed no learning deficits. More recently,
McIntyre et al. (2005) reported that infusion of AODs in
dorsal hippocampus impairs memory retention of an in-
hibitory avoidance task and that memory-altering drugs
injected in the basolateral amygdala could alter Arc/
Arg3.1 protein levels in dorsal hippocampus. Interest-
ingly, Kelly and Deadwyler (2003) have also reported
that animals that are either overtrained or slow in their
acquisition of a behavioral task have higher Arc/Arg3.1
mRNA levels compared to control animals.
In agreement with previous antisense studies, Arc/
Arg3.1 knockout mice have several memory deficits, as
they do not form either long-term spatial, fear, or taste
memories (Plath et al., 2006). In addition, Arc/Arg3.1
also participates in the processing of visual experience
by the visual cortex. Wang et al. showed that Arc/Arg3.1
regulates orientation selectivity in the visual cortex by
using in vivo two-photon microscopy in knockin mice
that have the Arc/Arg3.1 open reading frame replaced
with green fluorescent protein (GFP) (Wang et al.,
2006). These data are consistent with previous work
that showed a strong correlation between Arc/Arg3.1
expression and visual experience (Tagawa et al., 2005).
How does Arc/Arg3.1 affect memory formation? Re-
cent work has suggested that recycling of early endo-
somes contributes to the stable expression of LTP
(Park et al., 2004), while LTD requires clathrin-mediated
endocytosis (Carroll et al., 1999). As the study by
Neuron
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ulate AMPA receptor endocytosis and early endosome
recycling, it might not be surprising that genetic ablation
of Arc/Arg3.1 leads to impaired late-phase LTP and LTD
(Plath et al., 2006; Rial Verde et al., 2006).
The close relationship between Arc/Arg3.1 and LTD is
further supported by the study of Rial Verde et al. (2006).
In neurons, clathrin-mediated endocytosis occurs in
hotspots located perisynaptically through a series of
protein-protein and protein-lipid interactions (Blanpied
et al., 2002; Racz et al., 2004). For clathrin-mediated en-
docytosis and LTD to take place, the recruitment of the
adaptor protein 2 complex (AP2) is necessary. Previous
work has shown that peptides that inhibit the interaction
between GluR2 and AP2 prevent LTD (see Bredt and Nic-
oll, 2003, for review). Similarly, preventing the interaction
of GluR2 and AP2 also interferes with the ability of Arc/
Arg3.1 to downregulate AMPA-mediated synaptic trans-
mission, while overexpression of Arc/Arg3.1 in slice cul-
tures leads to the selective surface downregulation of
GluR2/GluR3-containing AMPA receptors. Furthermore,
Arc/Arg3.1 overexpression occludes LTD in slice cul-
ture, and phosphatase inhibitors that prevent LTD also
inhibit the ability of Arc/Arg3.1 to modulate AMPA-medi-
ated synaptic transmission (Rial Verde et al., 2006).
Arc/Arg3.1’s role is also extended to a newly discov-
ered form of plasticity—homeostatic synaptic plasticity,
or synaptic scaling (Davis, 2006). In cortical or hippo-
campal cultures, chronic blockade of neural activity
leads to a pronounced uniform enhancement of mEPSC
amplitudes (Turrigiano et al., 1998). The mechanism un-
derlying this phenomenon is unclear. It has recently
been reported (Stellwagen and Malenka, 2006) that
block of neural activity by TTX (voltage-gated sodium
channel blocker) decreases glutamate release, causing
the release of the cytokine TNF-a from glia cells. This
in turn, upregulates AMPA receptor-mediated synaptic
events through an unknown mechanism. In cultured
neurons with increased basal activity, Arc/Arg3.1 levels
are relatively high. Application of TTX in these cultured
neurons decreases Arc/Arg3.1 activity (Shepherd
et al., 2006). The decrease in Arc/Arg3.1 protein levels
correlates with a uniform increase of AMPA receptor
surface expression and mEPSC amplitudes, while over-
expression of Arc/Arg3.1 correlates with a uniform de-
crease of AMPA receptor surface expression and de-
crease in mEPSC amplitude. Most importantly, high
Arc/Arg3.1 protein levels induced through overexpres-
sion blocked homeostatic synaptic plasticity (Shepherd
et al., 2006). In agreement with the previous findings,
cultured neurons from Arc/Arg3.1 knockout mice have
increased AMPA receptor surface expression, and sub-
sequent treatment with TTX does not lead to homeo-
static synaptic plasticity. Together these data provide
persuasive evidence that Arc/Arg3.1 is implicated in ho-
meostatic synaptic plasticity. Future studies are neces-
sary to establish the link between TNF-a and Arc/Arg3.1.
Concluding Remark
The discovery of Arc/Arg3.1 a decade ago raised great
promise of being able to link gene expression to synap-
tic plasticity and behavior. However, until now the most
exciting finding involving Arc/Arg3.1 was based on its
ability to identify recently activated neurons. The recentpapers, especially those appearing in this issue of Neu-
ron, go a long way toward filling in the gap between our
knowledge of the expression of Arc/Arg3.1 and its pos-
tulated role in behavior. The linkage of Arc/Arg3.1 to
synaptic plasticity is compelling. It is induced by the
same stimuli that induce synaptic plasticity. It requires
the activation of NMDA receptors and is found exclu-
sively at activated synapses, as are most forms of syn-
aptic plasticity. The time course of Arc/Arg3.1 protein
expression correlates well with the time course of the
late phase of LTP, which requires protein synthesis. Fi-
nally, just as with synaptic plasticity, Arc/Arg3.1 is pro-
posed to mediate its effects by controlling the trafficking
of AMPA receptors, and learning and memory tasks are
impaired in mice lacking Arc/Arg3.1.
As is the case with any rapidly evolving field the recent
studies on Arc/Arg3.1 raise more questions than they
answer and suggest directions for future research. First,
if the sole function of Arc/Arg3.1, which is induced by
LTP-triggering stimuli, is to increase the rate of AMPA
receptor endocytosis, then it is difficult to explain its
role during LTP, which requires net insertion of AMPA
receptors. Why is LTP lost in the Arc/Arg3.1 knockout
mice? One might actually predict that it would be en-
hanced. Second, LTD is impaired in the Arc/Arg3.1
knockout mice, and overexpression of Arc/Arg3.1 oc-
cludes LTD, even though the stimulation protocols that
induce LTD are not known to significantly affect Arc/
Arg3.1 mRNA and protein levels. Therefore, the loss of
LTD in the Arc/Arg3.1 knockout mice may well be an in-
direct effect. Third, how is Arc/Arg3.1 protein seques-
tered at active synapses? Is it through its interaction
with CaMKII (Donai et al., 2003) and/or PSD-95? What
is the nature of the NMDA receptor-induced tag at acti-
vated synapses? Fourth, how does Arc/Arg3.1 selec-
tively control the endocytosis of AMPA receptors but
not NMDA receptors? If it doesn’t directly interact with
the receptors, what intermediary proteins are involved?
Fifth, evidence indicates that Arc/Arg3.1 is critically
involved in both LTP/LTD and synaptic homeostasis.
These two processes appear to have quite distinct
mechanisms, and, thus, it is unclear mechanistically
how Arc/Arg3.1 can be critical for both forms of plastic-
ity. Sixth, the enhancement of LTP for the first 30 min
and then a block thereafter in the Arc/Arg3.1 KO mouse
is intriguing but is difficult to explain with the currently
available data. Seventh, it is unclear why the Arc/Arg3.1
knockout doesn’t have reduced basal synaptic trans-
mission. This problem is reminiscent of a number of
knockout mice in which synaptic plasticity is altered
without any change in basal transmission. Given the
sudden upsurge of interest in Arc/Arg3.1 and the influx
of such a large amount of new and exciting data on the
role of Arc/Arg3.1, we can be certain that answers to
many of these questions will soon be forthcoming.
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